Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
Xalnesiran met of zonder immuunmodulator bij chronische hepatitis B
apr 2025 | Hepatitis, Virale infecties